INTERNATIONAL PATENT: HONGKONG BIOHENG BIOTECH LIMITED, 香港北恒生物科技有限公司 FILES APPLICATION FOR "ENGINEERED IMMUNE CELL AND USE THEREOF"

GENEVA, Feb. 24 -- HONGKONG BIOHENG BIOTECH LIMITED (Suite 603, 6/F, Laws Commercial Plaza, 788 Cheung Sha Wan Road, KowloonHong Kong 999077), 香港北恒生物科技有限公司 (中国香港特别行政区九龙长沙湾道788号罗氏商业广场6楼603室) filed a patent application (PCT/CN2023/112722) for "ENGINEERED IMMUNE CELL AND USE THEREOF" on Aug 11, 2023. With publication no. WO/2025/035309, the details related to the patent application was published on Feb 20, 2025.

Notably, the patent application was submitted under the International Patent Classif...